Yüklüyor......
Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
BACKGROUND: Delivering affordable cancer care is becoming increasingly important. Bevacizumab (BEV) is a costly molecular targeted agent effective for a variety of cancer including lung cancer. The objective of this review is to assess published economic evaluation of BEV in the treatment of non-sma...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3411370/ https://ncbi.nlm.nih.gov/pubmed/22870040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S27770 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|